Drugs / Hantaan Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02776761 | Aug 2016 → Sep 2017 | hantavirus infectious disease | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hantaan Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02776761 ↗ |
| Modality | Vaccine | “HTNV and PUUV DNA vaccines” NCT02776761 ↗ |
| Route | Intramuscular | “delivered intramuscularly IM by the needle-free PharmaJet Stratus DSJI device” NCT02776761 ↗ |